about
Mood stabilizing drug lithium increases expression of endoplasmic reticulum stress proteins in primary cultured rat cerebral cortical cellsInsulin-like growth factor binding protein-2 expression is decreased by lithiumOxidative damage to RNA but not DNA in the hippocampus of patients with major mental illness.Regulation of ER stress proteins by valproate: therapeutic implications.Differential effects of mood stabilizers on Fos/Jun proteins and AP-1 DNA binding activity in human neuroblastoma SH-SY5Y cells.Role of glutathione in neuroprotective effects of mood stabilizing drugs lithium and valproate.Chronic treatment with mood stabilizers lithium and valproate prevents excitotoxicity by inhibiting oxidative stress in rat cerebral cortical cells.Sensitization of C-fibres by prostaglandin E2 in the rat is inhibited by guanosine 5'-O-(2-thiodiphosphate), 2',5'-dideoxyadenosine and Walsh inhibitor peptide.Cyclic AMP mediates mu and delta, but not kappa opioid analgesia in the spinal cord of the rat.Regulation of GAP-43 expression by chronic desipramine treatment in rat cultured hippocampal cells.Chronic lithium treatment inhibits pilocarpine-induced mossy fiber sprouting in rat hippocampus.Identification of lithium-regulated genes in cultured lymphoblasts of lithium responsive subjects with bipolar disorder.Amygdala cyclic adenosine monophosphate response element binding protein phosphorylation in patients with mood disorders: effects of diagnosis, suicide, and drug treatment.Differential display polymerase chain reaction reveals increased expression of striatal rat glia-derived nexin following chronic clozapine treatment.Glucocorticoids increase protein carbonylation and mitochondrial dysfunction.Increased oxidative stress in the anterior cingulate cortex of subjects with bipolar disorder and schizophrenia.Lithium treatment prevents stress-induced dendritic remodeling in the rodent amygdala.Mood stabilizing drugs lamotrigine and olanzapine increase expression and activity of glutathione S-transferase in primary cultured rat cerebral cortical cells.Abstinence from repeated amphetamine treatment induces depressive-like behaviors and oxidative damage in rat brain.Decreased levels of glutathione, the major brain antioxidant, in post-mortem prefrontal cortex from patients with psychiatric disorders.G Protein-coupled cyclic AMP signaling in postmortem brain of subjects with mood disorders: effects of diagnosis, suicide, and treatment at the time of death.Identification of a novel lithium regulated gene in rat brain.Lithium and valproate differentially regulate brain regional expression of phosphorylated CREB and c-Fos.Decreased expression of insulin-like growth factor binding protein 2 in the prefrontal cortex of subjects with bipolar disorder and its regulation by lithium treatment.Immunoreactivity of 43 kDa growth-associated protein is decreased in post mortem hippocampus of bipolar disorder and schizophrenia.Mobilization of calcium from intracellular stores as one of the mechanisms underlying the antiopioid effect of cholecystokinin octapeptide.Effects of restraint stress on the expression of proteins involved in synaptic vesicle exocytosis in the hippocampus.Chronic restraint stress decreases the expression of glutathione S-transferase pi2 in the mouse hippocampus.Gene expression differences in bipolar disorder revealed by cDNA array analysis of post-mortem frontal cortex.Prefrontal cortex glutathione S-transferase levels in patients with bipolar disorder, major depression and schizophrenia.Mood stabilizer lithium inhibits amphetamine-increased 4-hydroxynonenal-protein adducts in rat frontal cortex.Increased expression of endoplasmic reticulum stress proteins following chronic valproate treatment of rat C6 glioma cells.Nitric oxide donor SIN-1 mediated down-regulation of the G-protein alpha-subunit in C6 glioma cells.C-fiber mechanical stimulus-response functions are different in inflammatory versus neuropathic hyperalgesia in the ratIncreased temporal cortex ER stress proteins in depressed subjects who died by suicideIncreased hippocampal BDNF immunoreactivity in subjects treated with antidepressant medicationCyclic AMP responsive element binding protein phosphorylation and DNA binding is decreased by chronic lithium but not valproate treatment of SH-SY5Y neuroblastoma cellsPlatelet protein kinase C alpha levels in drug-free and lithium-treated subjects with bipolar disorder
P50
Q28578375-54E068A0-33A8-4F8B-B823-A8334C6C9E36Q28580765-8A017567-22E1-419D-A5FF-7A190628CC85Q34084286-8C0E29B6-AC6D-4898-BA72-AF82B44B9AD1Q34692778-A21E3635-356B-4583-9E1B-D05A551ED434Q38335002-B1F64A9C-5E31-4B13-8F65-12A094A0FC7AQ40191233-0DAF6632-D2AA-4B7A-8912-22A7313B8915Q42480993-89B06F25-7682-4BDC-BE94-F1E54B733A36Q42553653-CE68FBB5-17C4-4B22-959F-9BBCA7884187Q44338070-B3F807D2-75AB-4604-96CB-D5A815C51D46Q44367032-B943D552-E33F-4E08-952D-4934060DD05EQ44464137-F9F24581-8549-4954-AAC6-EDD13E515FD8Q44736093-3D0B122E-769F-46B8-9830-5A982A70EF6AQ44795217-B70C1030-4B9D-4666-B17F-E15FCB76EA86Q45049137-D5DA531A-7C2F-430C-8B83-ABBF83CC8998Q45744474-A6FC26D2-44AA-47E6-8A42-C22760212D67Q45923132-C371D65A-D03A-4756-92FB-B263AE9299CEQ45980256-0DD5A64F-ECFF-487E-BCB8-77C532DE0281Q46018086-53954025-3D9E-4FA2-A0E3-EBD419C27089Q47919097-4D1367CC-FD5E-4DC2-8C87-957643769926Q48126851-389C4195-7535-4323-A4BF-92FBCD125CD5Q48127856-EFD0A60A-6909-4BFF-AD59-821EE719A760Q48178457-5AFEDCEB-F059-4358-A47A-6A4FEC5008EBQ48178479-634E0F8C-CF79-4967-B6DC-793B8B2432B4Q48224375-96D7B5A8-1F35-47EC-BD6F-800759AB5AA7Q48374794-54721223-516E-4F71-B182-089CB5136784Q48441298-798452C2-D539-4FA9-9D87-0BF72087C806Q48508339-21E70D44-87A4-4CDF-A26C-75685401447FQ48564873-D41BB586-FB3C-4EE5-9076-7D6497F12F4AQ48704345-6C2C84DC-6A9C-4261-A8D4-48E8AA7DAB79Q48831154-029CC3CE-F8D0-4D49-AB4F-B375C0D8800FQ48883763-AFB5AE6E-3809-43C6-893D-F8143A94B076Q55475244-71C1662B-F43D-4613-BBAB-33C61D4CA25AQ55479006-B84F71D6-6F9E-48D2-B988-6FEF72AF9A54Q71911464-A70949C0-3CAA-4297-8892-31BF8F71D821Q73489072-032B17CD-9107-46CF-A63B-4630408D6AFCQ74424004-E41BFD51-6E26-4904-93E2-4B3C1256D05BQ77872729-6A138C82-B735-446D-94D5-E58F09083A4EQ78209431-9E919ADD-29EF-4FCC-BEB9-4E0668783AD4
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Jun-Feng Wang
@ast
Jun-Feng Wang
@en
Jun-Feng Wang
@es
Jun-Feng Wang
@nl
Jun-Feng Wang
@sl
type
label
Jun-Feng Wang
@ast
Jun-Feng Wang
@en
Jun-Feng Wang
@es
Jun-Feng Wang
@nl
Jun-Feng Wang
@sl
prefLabel
Jun-Feng Wang
@ast
Jun-Feng Wang
@en
Jun-Feng Wang
@es
Jun-Feng Wang
@nl
Jun-Feng Wang
@sl
P106
P1153
36098500000
P31
P496
0000-0002-4672-566X